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Aquaporin-1 Deficiency Protects 
Against Myocardial Infarction 
by Reducing Both Edema and 
Apoptosis in Mice
Lihua Li1, Zhiyong Weng1, Chenjuan Yao2, Yuanlin Song3 & Tonghui Ma4
Many studies have determined that AQP1 plays an important role in edema formation and 
resolution in various tissues via water transport across the cell membrane. The aim of this research 
was to determine both if and how AQP1 is associated with cardiac ischemic injury, particularly 
the development of edema following myocardial infarction (MI). AQP1+/+ and AQP1−/− mice were 
used to create the MI model. Under physiological conditions, AQP1−/− mice develop normally; 
however, in the setting of MI, they exhibit cardioprotective properties, as shown by reduced cardiac 
infarct size determined via NBT staining, improved cardiac function determined via left ventricular 
catheter measurements, decreased AQP1-dependent myocardial edema determined via water 
content assays, and decreased apoptosis determined via TUNEL analysis. Cardiac ischemia caused 
by hypoxia secondary to AQP1 deficiency stabilized the expression of HIF-1α in endothelial cells 
and subsequently decreased microvascular permeability, resulting in the development of edema. 
The AQP1-dependent myocardial edema and apoptosis contributed to the development of MI. 
AQP1 deficiency protected cardiac function from ischemic injury following MI. Furthermore, AQP1 
deficiency reduced microvascular permeability via the stabilization of HIF-1α levels in endothelial 
cells and decreased cellular apoptosis following MI.
Myocardial infarction (MI) may result in myocardial edema, which is directly associated with mortality 
due to impairment in both left ventricular systolic and diastolic function1–3. Myocardial edema occurs 
primarily as a result of irreversible myocardium injury secondary to myocyte swelling, which results 
in cardiac dysfunction4,5. Increased myocardial microvascular filtration rates and decreased myocardial 
lymph flow rates are two major factors associated with the development of interstitial myocardial edema 
following MI6. However, increased microvascular permeability does not necessarily cause myocardial 
edema7. Therefore, another mechanism may be associated with this process. However, data are limited 
concerning the molecular mechanisms underlying the development of myocardial edema following MI.
Aquaporins (AQPs) are water-transporting membrane proteins selectively expressed in the cells of 
various organs, wherein they perform important physiological functions3,4,8–11. Several studies involv-
ing AQP1 knockout mice have demonstrated that AQP1 is expressed in the microvasculature and the 
endothelium of cardiac tissue as determined via Western blotting and RT-PCR. AQP1 also facilitates 
osmotic water transport in cardiac membrane vesicles, although previous immunostaining studies have 
been unable to confirm its presence in cardiac myocytes12. AQP4 has been detected within mouse hearts 
at the protein level13 and has a water transport capacity as much as 24 times that of AQP1; however, 
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AQP4 has not been shown to increase the water permeability of cardiac membrane vesicles14. Therefore, 
AQP4 is considered physiologically irrelevant in the mouse heart15. Recent studies have implicated AQP1 
as a mediator of cardiac damage in the setting of both myocardial ischemia and edema.
The significance of cardiac AQP1 expression and its related functions remain unclear. Therefore, we 
investigated the role of AQP1 following MI by comparing heart morphology, infarct size, myocardial 
water content, cardiac function and hypoxia-inducible factor-1α (HIF-1α ) levels and cellular apoptosis 
between AQP1−/− and AQP1+/+ mice. We observed that AQP1 deficiency significantly decreased myo-
cardial infarct size, and also markedly reduced cardiac edema, stabilized HIF-1α levels and decreased 
both microvascular permeability and cellular apoptosis following MI, which may have been responsible 
for the improvements in the cardiac function of the AQP1 deficient mice.
Results
Cardiac non-changes due to AQP1 deficiency. Figure  1a, top, depicts the normal hearts of the 
AQP1+/+ and AQP1−/− mice. The hearts of the AQP1+/+ and AQP1−/− mice exhibited similar sizes, gross 
anatomical features and weights [Fig. 1(a), bottom]. H&E staining demonstrated that the hearts of the 
AQP1+/+ and AQP1−/− mice exhibited similar histological features, as well as comparable myocardium 
thicknesses and myocyte densities [Fig. 1(b)]. AQP1 immunohistochemistry staining demonstrated that 
the endothelial cells exhibited expression patterns consistent with those of normal human hearts and 
AQP1+/+ mouse hearts [Fig. 1(d)], as brown staining was visible across the membranes of the endothelial 
cells and limited staining of the myocytes was visible. No specific staining was observed in the hearts of 
the control slices. The expression of AQP1 in human heart exhibits a pattern similar to that observed in 
the mouse heart.
Figure 1(c), top, depicts RT-PCR with respect to mouse AQP1; cardiac RNA expression in both the 
AQP1+/+ and the AQP1−/− mice was used as template. The expression of the transcript encoding AQP1 
was observed in the hearts of the wild type mice using cDNA. The Western blot analysis of the expres-
sion level of AQP1 protein in both the AQP1+/+ and the AQP1−/− mice is depicted in Fig. 1(c), bottom. 
Figure 1. Normal cardiac morphology and the expression of AQP1 in AQP1−/− and AQP1+/+ mice. 
((a) top) Heart images from the AQP1−/− and AQP1+/+ mice. ((a) bottom) The heart weight/body weight 
ratio was representative of adult mice at 8–10 weeks age. The values are expressed as the mean ± SEM. 
(n = 6, differences not significant). (b) Heart sections from the AQP1−/− and AQP1+/+ mice stained with 
H&E. Scale bar: 50 μ m. (c) The RT-PCR (top) and Western blot (bottom) analyses demonstrate the relative 
expression levels of AQP1 in the AQP1−/− and AQP1+/+ mice hearts. Kidney tissue was used as positive 
control. (d) The AQP1 expression pattern in the normal hearts of both humans (left) and mice (right) as 
demonstrated via immunohistochemistry. Scale bar: 50 μ m.
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Strong expression bands of AQP1 mRNA and protein were observed in the hearts of the AQP1+/+ mice. 
Kidney tissue was used as a positive control.
AQP1 deficiency reduced myocardial infarct size following MI. In order to assess the severity of 
cardiac injury following MI, cardiac infarct size was measured via NBT staining on day 2 following MI 
in the AQP1+/+ and AQP1−/− mice [Fig.  2(a)]. Compared with the AQP1+/+ mice, the AQP1−/− mice 
exhibited significantly smaller infarct size [Fig. 2(b)]. Small infarct sizes were also observed in the con-
trol group (sham operated mice) compared with the AQP1+/+ and AQP1−/− mice [Fig. 2(b)]. In order 
to determine if infarct size reduction was a generalized phenomenon in the AQP deficient mice, we 
also induced MI in AQP3−/− mice and measured myocardial infarct sizes. No differences were observed 
between the AQP3+/+ and AQP3−/− mice; however, myocardial infarct size was markedly reduced in the 
AQP1−/− mice compared with the AQP3−/− mice [Fig. 2(b)]. Figure 2(c) depicts the expression of AQP1 
following MI, as said expression was up-regulated compared with before MI. These findings suggest that 
compensatory upregulation of the other AQPs exerted protective effects in the AQP1−/− mice. We also 
analyzed the expression of the other AQPs following MI via RT- PCR. However, none of the other AQPs 
expression levels was up-regulated in the AQP1−/− mice (data not shown). These results are indicative 
of the involvement of AQP1 in both the pathophysiology and the impairments that occur following MI.
AQP1 deficiency protected cardiac contractile function following MI. In order to determine 
the role of AQP1 in cardiac function following MI, we assessed HR, LVSP, LVEDP, + dP/dtmax and 
− dP/dtmin in vivo at 18 hours following MI using an LV catheter that simultaneously measures pressure, 
as depicted in Fig. 3(a). LVSP (b), HR (c), and + dP/dtmax (e), as well as − dP/dtmin (f), were significantly 
decreased in the AQP1+/+ and AQP1−/− MI mice, whereas LVEDP (d) was increased compared with 
the control mice. However, LV + dP/dtmax and − dP/dtmin were greater, and LVEDP was smaller in the 
Figure 2. AQP1 deficiency reduced myocardial infarct size at 2 days following MI. ((a) top) depicts 
representative images of the heart in situ, with ligation of the left anterior descending coronary artery. ((a) 
bottom) depicts representative samples of heart slices taken at the mid-papillary muscle level following 
MI. The perfused myocardium was stained using Evans blue solution, whereas the occluded vasculature 
remains uncolored. The arrow indicates the ischemic site. (b) The infarct size is expressed as the percentage 
of the area at risk, AR. The data are expressed as the mean ± SEM (n = 15, *P < 0.001 vs sham. ##P < 0.01 
vs AQP1+/+ and AQP3−/− MI mice). (c) Quantitative real-time RT-PCR demonstrating AQP1 expression in 
cardiac tissue following MI 0 day and day 2. The values are expressed as the mean ± SEM (n = 6, *P < 0.01 
vs. day 0).
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AQP1−/− mice compared with the AQP1+/+ mice. These results suggest that AQP1 deficiency protected 
against cardiac functional impairment following MI.
AQP1 deficiency attenuated myocardial edema following MI. AQP-facilitated plasma mem-
brane water permeability reportedly promotes the development of edema in a variety of tissues8. In 
order to determine whether this mechanism is applicable to cardiac tissue, we assessed the development 
of AQP1-dependent myocardial edema following MI via the following methods: a myocardial water 
content assay and microvascular permeability assay. We first compared myocardial water content in the 
AQP1−/− and AQP1+/+ mice at both 18 and 36 h following MI. As demonstrated in Fig. 4(a), MI caused 
in increase in the water content of the myocardium interstitial space, as determined via H&E stain-
ing. The AQP1−/− mice exhibited significant smaller myocardial interstitial spaces compared with the 
AQP1+/+ mice. Figure 4(b) also depicted similar reductions in the water content of the AQP1−/− MI mice 
using both the wet and dry weights of the infarct myocardium. The edema peaked at 36 h following MI 
in the AQP1+/+ mice. The microvascular permeability assay exhibited no significant differences between 
the AQP1−/− and AQP1+/+ mice secondary to FITC-dextran leakage, at 18 h following MI, as demon-
strated in Fig.  4(c). These results support the involvement of AQP1 in the development of myocardial 
edema following MI. However, at 36 h following MI, FITC-dextran leakage was significantly increased 
in the AQP1+/+ MI mice compared with the AQP1−/− MI mice. As AQP1−/− mice suffer water loss 
under stress due to deficient kidney re-absorption, we used AQP3−/− mice in order to avoid water loss. 
However, no differences were observed in myocardial water content between the AQP3+/+ and AQP3−/− 
mice (data not shown). These results indicated that increased microvascular permeability exacerbated 
AQP1-dependent myocardial edema.
AQP1 deficiency stabilized the expression of HIF-1α following MI. In order to determine the 
cellular mechanisms underlying AQP1-dependent myocardial edema, we examined HIF-1α levels in 
cardiac tissue following MI. Increases in the HIF-1α levels of vascular endothelial cells represent one 
of the earliest responses to myocardial ischemia and infarction16. Our previous in vitro studies have 
Figure 3. The effects of AQP1 deficiency on cardiac contractile function following MI. (a) A 
representative tracing of LV hemodynamic recordings obtained in vivo using a conductance catheter in 
both the sham-operated mice and both the AQP1−/− and AQP1+/+ mice at 18 hours following MI. (b) The 
LV systolic pressures (LVSPs) (n = 12), heart rates (HRs) (n = 12) (c), LV end-diastolic pressures (LVEDPs) 
(n = 12) (d) and maximal positive (e) and minimal negative (f) first derivatives of LV pressure (+ dP/dtmax 
and –dP/dtmin) (n = 12). The values are expressed as the mean ± SEM. *P < 0.01 vs sham; #P < 0.05, 
##P < 0.01 vs AQP1+/+ MI mice.
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demonstrated that AQPs facilitate the secretion of specific cytokines17. Therefore, the HIF-1α level dur-
ing the early phase of MI was assayed via immunoblotting. Figure 5(a) demonstrates that the expression 
of HIF-1α in the AQP1+/+ MI mice was significantly increased compared with the AQP1−/− MI mice. 
Moreover, the level of AQP1 expression in the MI mice was also increased compared with the control 
mice [Fig.  5(b)]. The level of HIF-1α expression correlated with AQP1 expression and reinforced its 
involvement in MI.
AQP1 deficiency inhibited cardiac apoptosis following MI. In order to determine whether 
AQP1-dependent myocardial edema mediates cardiac myocyte injury, an apoptosis analysis was under-
taken using terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining, and 
revealed that in non-ischemic heart tissue, the number of apoptotic cells were similar in both the 
AQP1+/+ MI mice and the AQP1−/− MI mice. However, the number of apoptotic cells in the ischemic 
heart tissue of the AQP1+/+ mice was significantly increased compared with the AQP1−/− mice follow-
ing MI [Fig.  6(a)]. In order to confirm the above results, we analyzed the expression of the apoptosis 
proteins caspase3, bax and bcl-2 via immunoblotting. As expected, the expression levels of caspase3 and 
bcl-2 were significantly increased in the AQP1+/+ mice compared with the AQP1−/− mice following MI, 
whereas bax expression was significantly decreased in the AQP1+/+ mice compared with the AQP1−/− 
mice [Fig.  6(b)]. These results indicated that AQP1 deficiency protected against the development of 
cardiac dysfunction by attenuating cardiac apoptosis.
Discussion
To date, cardiac AQPs have not been investigated to the degree that renal and brain AQPs have been. 
Previous studies have described multiple AQP expression patterns in the heart via RT-PCR and Western 
blotting15, and have also demonstrated that AQP1 and AQP4 are expressed in the mouse heart; however, 
the water permeable AQP4 has not been detected in the cardiac vesicles of mice. Controversy exists 
regarding the functional roles of AQPs18–20. Evidence pertaining to AQP1 expression in the heart is 
consistent with the data from this study. Our studies have demonstrated that AQP1 is highly expressed 
within endothelial cell membranes as opposed to myocardial cells, in mice. This pattern of AQP1 expres-
sion is an important determinant of its function. However, the physiologic, metabolic, and anatomic 
effects of AQP1 expression in cardiac tissue are not different under physiological conditions in both 
AQP1+/+ and AQP1−/− mice.
Figure 4. The effects of AQP1 deficiency on myocardial edema following MI. (a) Myocardial interstitial 
edema was observed via H&E staining in the AQP1+/+ (left) and AQP1−/− mice (right) at 18 h following 
MI. Scale bar: 100 μ m. (b) A quantitative analysis of myocardial water content at 0 h, 18 h and 36 h following 
MI in the AQP1−/− and AQP1+/+ mice using both dry and wet weights. The values are expressed as the 
mean ± SEM (n = 12, *P < 0.05, **P < 0.01 vs 0 h. ##P < 0.01 vs AQP1+/+ mice at 18 h and 36 h).  
(c) A quantitative analysis of microvascular permeability via measurements of FITC-dextran leakage using 
spectrophotometry (n = 6, *P < 0.05, **P < 0.01 vs 0 h. ##P < 0.01 vs AQP1+/+ mice at 36 h).
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Although previous studies have provided functional data indicative of the involvement of AQP1 in 
cardiac pathophysiology12, said data has not enabled researchers to elucidate the relationship between 
AQP1 expression and cardiac ischemia and infarction in mice. The findings of this study demonstrated 
the role played by AQP1 in the regulation of cardiac function following MI. Increased AQP1 expression 
levels were observed in cardiac tissue following the ligation of the LAD. AQP1 gene knockout in mice 
resulted in preserved LV function and reduced interstitial edema, as well as enhanced survival (data 
not shown). Infarct size is the most critical determinant of myocardial injury and mortality following 
MI21. The results of p-nitro-blue tetrazolium staining were characterized by reduced myocardial infarct 
size, and a serum analysis of myocardial enzyme levels (data not shown) demonstrated reduced cardiac 
injury following the ligation of the LAD in the AQP1−/− mice. We also induced MI in AQP3−/− mice 
in order to determine if AQP3 deficiency resulted in impaired kidney water absorption and decreased 
cardiac load22. We surmised that other AQPs may compensate for the absence of AQP1. Similar infarct 
sizes, myocardial enzyme levels and myocardial water content were observed in both the AQP3+/+ and 
the AQP3−/− mice following MI. These findings support the hypothesis that AQP1 is associated with the 
pathophysiology of MI.
Edema is a generic component of the tissue response to acute injury. Myocardial ischemia, infarction 
and apoptosis may induce the development of myocardial edema, which contributes to cardiac dysfunc-
tion. The enhanced tissue edema development has been noted in several distinct AQPs such as AQP110, 
AQP48 and AQP59 in many tissue types, suggesting that AQP-facilitated transmembrane water transport 
is responsible for the development of edema. Therefore, in the setting of conditions in which altered 
water homeostasis occurs, myocardial interstitial space enlargement occurs due to the efflux of fluid 
from the vascular compartment via AQP1, resulting in myocardial edema. Many studies have determined 
that small increases in myocardial water content are associated with significant ventricular systolic and 
diastolic dysfunction during the acute stage of MI23–27.
In the present study, we chose the time point of 18 h following the ligation of the LAD as the optimal 
time for the measurement of myocardial water content. Myocardial edema develops and peaks earlier 
than necrosis28. AQP1-dependent myocardial interstitial edema was reduced in the AQP1−/− mice and 
correlated strongly with attenuations in myocardial injury but did not significantly ameliorate defec-
tive microvascular leakage following MI, with the exception of attenuating endothelial permeability. 
AQP1, a facilitator of endothelial cell water transport, represents the primary pathway by which the 
influx of O2 into epithelial cells the efflux of intracellular O2 to myocardial cells occurs29–31. However, 
AQP1-dependent myocardial edema increases the distance between coronary arterial supply and cardi-
omyocytes and prolongs oxygen diffusion in the myocardial interstitium, resulting in the exacerbation 
of myocardial ischemia, cellular apoptosis and worsening infarction32,33.
Figure 5. The effects of AQP1 deficiency on the expression of HIF-1α and AQP1 at 24 hours after MI. 
(a) Photographs and a quantitative analysis of the expression of HIF-1α via Western blotting in the AQP1−/− 
and AQP1+/+ mice. The HIF-1α expression level was significantly increased following MI in the AQP1+/+ 
mice compared with the AQP1−/− mice (n = 6, *P < 0.01 vs sham. ##P < 0.01 vs AQP1+/+ MI mice).  
(b) Photographs and a quantitative analysis of the expression of AQP1 via Western blotting in the AQP1+/+ 
MI mice compared with the sham-operated AQP1+/+ mice (n = 6, *P < 0.01).
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Additional key mechanisms underlying the development of severe cardiac injury in AQP1+/+ mice 
following MI may also involve the release of cytokines via AQP1 in endothelial cells in the setting of 
ischemia17. When the myocardium is deprived of blood secondary to coronary artery occlusion, ischemia, 
infarction, and myocardial remodeling are initiated. HIF-1α is one of the earliest responses to myocardial 
ischemia and infarction16.
During the early phase of MI, the level of HIF-1α expression was rapidly upregulated in the AQP1+/+ 
mice compared with the AQP1−/− mice. The upregulation of AQP1 expression in endothelial cells affects 
not only water permeability but also O2 transport, which facilitates cytosolic O2 diffusion across the 
cell membrane34, resulting in the up-regulation of the expression of HIF-1α ; however, AQP1 deficiency 
results in increased HIF-1α levels, which may contribute to cell death, tissue destruction, and the devel-
opment of edema35. Additionally, recent study demonstrated that the genetic sequence of AQP1 is iden-
tical to the consensus sequence of the HIF-1α binding site29. Our results are indicative of a strong 
correlation between increased HIF-1α levels and the up-regulation of AQP1 expression, both of which 
may exacerbate the development of edema via increased microvascular endothelial permeability at 36 h 
following MI in AQP1+/+ mice. By contrast, AQP1 deficiency slightly increased both HIF-1α levels and 
myocardial edema, a finding that suggests that HIF-1α and AQP-1 are part of a single molecular cascade. 
Therefore, it is possible that HIF-1α may be induced by ischemia, resulting in increased microvascular 
permeability and AQP1-dependent myocardial edema.
In conclusion, we have demonstrated that AQP1 deficiency attenuates infarct size. Our results also 
suggest that the underlying mechanisms for this salutary effect may involve the inhibition of the develop-
ment of AQP1-dependent myocardial edema, as well as decreased AQP1-dependent HIF-1α expression 
in endothelial cells, which decreases endothelium permeability and results in both decreased edema and 
decreased cellular apoptosis. Our results suggest that AQP1 inhibitors may represent a novel therapeutic 
target in the modulation of cardiac function in the setting of myocardial ischemia and injury.
Figure 6. The effects of AQP1 deficiency on cardiomyocyte apoptosis following MI. (a) A quantitative 
analysis of apoptotic cells in the hearts of mice via a TUNEL assay (n = 6, *P < 0.001 vs sham. ##P < 0.01 vs 
AQP1+/+ MI mice). TUNEL quantification was based on 6 fields per heart and 6 hearts per group.  
(b) The heart tissues from the AQP1+/+ and AQP1−/− mice at 48 h following MI were lysed and subjected 
to Western blotting in order to analyze the expression of caspase-3, bcl-2 and bax. (c) Band densities were 
measured using Image J software and normalized to β -actin. The data are expressed as the mean ± SEM 
(n = 6, *P < 0.01 vs sham; #P < 0.05, ##P < 0.01 vs AQP1+/+ MI mice).
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Materials and Methods
Mice. AQP1−/− and AQP3−/− mice with a CD1 genetic background were generated via targeted 
gene disruption as described previously36. CD1 male mice and eight- to ten-week old and age-weight-
matched AQP1−/− and AQP3−/− mice were used. The mice were maintained in a specific pathogen-free 
grade animal facility under a 12-h light-dark cycle. All procedures were approved by the Committee on 
Animal Research of Dalian Medical University and followed the ARRIVE guidelines pertaining to animal 
experimentation37.
Induction of MI. MI was induced via permanent ligation of the left anterior descending (LAD) cor-
onary artery in the AQP1+/+ and AQP1−/− mice, as previously described, with modification38,39. Briefly, 
the mice were anesthetized via 2% isoflurane inhalation but not ventilated and were fixed on an animal 
operating table with a heating pad. Under sterile conditions, a left thoracotomy was performed through 
the 4th left intercostal space in order to expose the heart, and a 6–0 sterile silk suture was passed rapidly 
under the LAD, just below the tip of the left auricle. The control subjects underwent a sham operation in 
which no ligation took place. The heart was subsequently replaced in the intra-thoracic space, followed 
by the manual evacuation of any air and the closure of both the overlying muscle and the skin. The mice 
were placed on a heating pad while recovering from the anesthesia. The chest cavity was open for only 
a few seconds, as the mice would have died in the absence of mechanical ventilation. The survival rate 
for each surgery group ranged from 80%–90%.
Measurement of infarct size. After 48 hours, the mice were anesthetized with 2% isoflurane inhala-
tion and received injections of 1% Evans blue dye (i.v.) in order to stain the ischemic area at risk (AR). 
The hearts were then arrested during diastole via the administration of 10% potassium chloride through 
the right carotid artery, before being removed and cut into 3 transverse sections as follows: apex, middle 
and root ring (3 mm in thickness). The perfused myocardium was stained using Evans blue solution, 
whereas the occluded vasculature remained uncolored. After removing the right ventricular wall, the AR 
and non-ischemic myocardium were separated by following a line of demarcation between the stained 
tissue and the unstained tissue. In order to distinguish between the ischemic and the infarcted tissue, 
the AR was cut into small pieces and incubated with p-nitro-blue tetrazolium (NBT, 0.5 mg/ml, 20 min 
at 37 °C, pH 7.4) to stain the viable myocardium blue-red. In the presence of intact dehydrogenase 
enzymes (normal myocardium), NBT forms a dark blue formazan; areas of necrosis lack dehydrogenase 
activity and therefore do not stain40. Both the AR and the infarct size were calculated and expressed as 
a percentage of the AR. The total and infarct areas of the left ventricle were measured using planimeter 
in a double-blinded manner.
Assessment of hemodynamics. At 18 hours following MI, the mice were anesthetized via the inha-
lation of 2% isoflurane with ventilation; rectal temperatures were maintained between 36.7 and 37.3 °C. 
The left ventricle (LV) was catheterized using a conductance catheter connected to a pressure transducer 
(Chengdu Taimeng Technology Corp., LTD) via the right common carotid artery and carefully intro-
duced into the LV in order to measure the heart rate (HR), systolic pressure (LVSP), and end-diastolic 
pressure (LVEDP), as well as the maximum and minimum rates of left ventricular pressure development 
(+ dP/dtmax and − dP/dtmin, respectively)41. LV pressure was recorded at steady state for 3–5 min using a 
4 channel data acquisition system (Chengdu Taimeng Technology Corp., LTD).
Measurement of myocardial water content (%MWC). Myocardial water content was analyzed at 
both 18 and 36 hours following MI in the AQP1+/+ and AQP1−/− mice as previously described42. In brief, 
the mice were anesthetized via the inhalation of 2% isoflurane, and the left ventricle was perfused with 
PBS. The hearts were subsequently arrested during diastole with 10% potassium chloride before being 
removed and dried with filter paper and weighed, before being dried again in a heat oven at 80 °C for 
72 hours. The dried hearts were re-weighed, and the percentage of myocardial water content was calcu-
lated as [(wet weight-dry weight)/wet weight] × 100.
Assay of microvascular permeability. The mice were injected intravenously with 10% 
fluorescein-isothiocyanate (FITC)-dextran (1.5 ml/kg; 40 kDa, Sigma, USA) 15 min before they were 
euthanized as previously described43. At 18 and 36 hours following MI, the mice were anesthetized via 
the inhalation of 2% isoflurane, and the left ventricle was perfused with PBS. The hearts were removed 
and homogenized before being centrifuged at 12,000 × g for 15 min at 4 °C. The fluorescent concentra-
tion in the supernatant was measured using a fluorescence spectrophotometer (an excitation wavelength 
495 nm and an emission wavelength 517 nm). A standard curve was prepared using known amounts 
of FITC-dextran in order to calculate the concentrations in and the total amounts recovered from the 
cardiac tissues.
Histopathology and immunostaining. The mice were anesthetized via the intraperitoneal injec-
tion of phenobarbital sodium (65 mg/kg) and perfused transcardially with 4% paraformaldehyde in PBS. 
The hearts were removed and fixed for 24 hours in 4% paraformaldehyde at 20 °C. The tissues were 
dehydrated using increasing concentrations of ethanol and embedded in paraffin. The sections were 
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deparaffinized and stained using hematoxylin and eosin (H&E) in order to detect cardiac edema and 
morphological changes.
For AQP1 immunohistochemistry, the paraffin-embedded sections were cut at a thickness of 5 μ m 
and deparaffinized before being treated with citrate buffer using microwave antigen retrieval and 3% 
hydrogen peroxide. The sections were incubated for 2 hours with a primary AQP1 antibody (1:100, Santa 
Cruz, CA, USA) before being incubated with a biotinylated secondary antibody (1:500, Vector Labs, 
Burlingame, CA, USA) and an avidin-biotin peroxidase complex (1:500, Vector Labs, Burlingame, CA, 
USA). Peroxidase labeling was visualized using diaminobenzidine (Vector Labs, Burlingame, CA, USA), 
which yielded a brown color.
In order to analyze the apoptotic cells, five-micrometer sections were prepared. The sections were 
subsequently stained using a fluorescein in situ cell death detection kit (Roche, Basel, Switzerland). Six 
images per heart (6 hearts per genotype group) were acquired. The number of TUNEL-positive cells per 
section was counted and calculated as a percentage of all nuclei according to the manufacturer’s protocol.
RT-PCR and Western Blot Analysis. For RT-PCR, total RNA was isolated from mice via 
homogenization in TRIzol reagent (Invitrogen, Carlsbad, CA, USA). Following reverse transcrip-
tion, PCR was completed using gene-specific primers designed to amplify the mouse AQP1 cod-
ing sequence. The primers were as follows: 5′ -TGTATGCCTCTGGTCGTACC-3′ (sense) and 
5′ -CAGGTCCAGACGCAGGATG-3′ (antisense) for β -actin, and 5′ -CTCCCTAGTCGACAATTCAC-3′ 
(sense) and 5′ -ACAGTACCAGCTGCAGAGTG-3′ (antisense) for AQP1. Fluorescence-based real-time 
reverse transcription-PCR (RT-PCR), using 2 μ g cDNA, was carried out using a LightCycler with 
FastStart DNA MasterPLUS SYBR Green I kit (Roche Diagnostics, Indianapolis, IN, USA). β -actin was 
used as a reference gene, and pooled cDNA from the AQP1+/+ mice, both before and after MI, was used 
as a calibrator. The results were reported as normalized and calibrated ratios.
For Western blotting, the mouse heart tissues were homogenized and centrifuged at 5,000 × g for 
10 min. The supernatant was subjected to 10% SDS-polyacrylamide gel (20 μ g of protein/lane) electro-
phoresis and transferred to a polyvinylidene difluoride membrane. The membrane was subsequently 
incubated with a primary antibody (1:100 or 1:500, Santa Cruz Biotechnology, Abcam, Cell signaling or 
Invitrogen, USA) overnight at 4 °C. Following washing with TBS, the membrane was incubated with a 
horseradish peroxidase (HRP)-linked secondary antibody at room temperature for 1 hour in the dark. 
The bands were developed using enhanced chemiluminescence (ECL; Thermo Scientific, Rockford, IL) 
and exposed on X-ray films (LIEGTLABS, Dallas, TX, USA). Band density was analyzed using ImageJ 
software.
Statistical analysis. The data are presented as the mean ± standard error of the mean (SEM). All 
experiments were performed in triplicate. All data were estimated using Student’s t-test for two-group 
data sets and one-way ANOVA followed by Bonferroni’s post-hoc test to compare more than two groups, 
using GraphPad Prism, version 5.0 software. Statistical significance was determined as P < 0.05.
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